Stroke remains the leading cause of disability and a major cause of death among Americans. This grant seeks to illuminate fundamental processes driving development of the inflammatory and coagulant phenotype of cerebral microvessels in stroke. Preliminary data in murine stroke shows that upregulated expression of leukocyte adhesion receptors (ICAM-1, P- and E-selectin), GPIIb/IIIa-receptor mediated aggregation of platelets, and diminished endogenous fibrinolysis are all contributory. New data suggests that ischemic vascular stress initiates a pathway leading from protein kinase C (PKC) betaII activation to rapid induction of the early growth response-1 gene (Egr-1), a transcription factor which triggers expression of target genes which modulate the pathological ischemic vascular phenotype. These targets include inflammatory (cytokine/chemokine), leukocyte adhesion receptor, prothrombotic, antifibrinolytic, and permeability-inducing genes. As mice null for PKCbeta or Egr-1 are significantly protected from pulmonary ischemic injury, and because Egr-1 mRNA and protein are increased in the ischemic brain, we hypothesize that Egr-1 serves as a """"""""master switch,"""""""" whose induction during cerebral ischemia may trigger pathological downstream events leading to micro vascular failure and increased tissue injury in stroke.
We Aim (1) To elucidate the pathological role of Egr-1 in micro vascular failure in stroke, using Egr 1+/+ and Egr-1-/- mice to examine stroke outcomes as well as induction of Egr-1 target genes; (2) To determine whether an event upstream of Egr-1, activation of PKCbetaII, has a role in micro vascular failure in stroke. These studies will use PKCbeta null mice and unique transgenic mice with macrophage-targeted expression of wild type, dominant negative, or constitutively active PKCbetaII driven by the type A macrophage scavenger receptor; (3) To identify alternative mechanisms which may link coagulant and inflammatory axes in the setting of stroke. Microarrays will be used for gene expression profiling in ischemic brains from Egr-1+/+ and Egr-1-/- mice, a detailed promoter analysis will be undertaken for a prototypical hypoxia-inducible, Egr-1 responsive gene (plasminogen activator inhibitor-1), and a post-transcriptional link between inflammation and thrombosis in stroke will be examined in P-selectin null mice. Overall these studies will identify unifying molecular events which link micro vascular coagulation and inflammation in stroke.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL059488-07
Application #
6687793
Study Section
Special Emphasis Panel (ZRG1-BDCN-3 (01))
Program Officer
Ganguly, Pankaj
Project Start
1998-09-30
Project End
2006-11-30
Budget Start
2003-12-01
Budget End
2004-11-30
Support Year
7
Fiscal Year
2004
Total Cost
$321,567
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Ducruet, Andrew F; Sosunov, Sergey A; Visovatti, Scott H et al. (2011) Paradoxical exacerbation of neuronal injury in reperfused stroke despite improved blood flow and reduced inflammation in early growth response-1 gene-deleted mice. Neurol Res 33:717-25
Liao, Hui; Hyman, Matthew C; Lawrence, Daniel A et al. (2007) Molecular regulation of the PAI-1 gene by hypoxia: contributions of Egr-1, HIF-1alpha, and C/EBPalpha. FASEB J 21:935-49
Harada, Hiroaki; Lama, Vibha N; Badri, Linda N et al. (2007) Early growth response gene-1 promotes airway allograft rejection. Am J Physiol Lung Cell Mol Physiol 293:L124-30
Mishra, Snigdha; Fujita, Tomoyuki; Lama, Vibha N et al. (2006) Carbon monoxide rescues ischemic lungs by interrupting MAPK-driven expression of early growth response 1 gene and its downstream target genes. Proc Natl Acad Sci U S A 103:5191-6
Mocco, J; Mack, William J; Ducruet, Andrew F et al. (2006) Complement component C3 mediates inflammatory injury following focal cerebral ischemia. Circ Res 99:209-17
Marcus, Aaron J; Broekman, M Johan; Drosopoulos, Joan H F et al. (2005) Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection. Semin Thromb Hemost 31:234-46
Ten, Vadim S; Sosunov, Sergei A; Mazer, Sean P et al. (2005) C1q-deficiency is neuroprotective against hypoxic-ischemic brain injury in neonatal mice. Stroke 36:2244-50
Ten, Vadim S; Wu, Ed X; Tang, Haiying et al. (2004) Late measures of brain injury after neonatal hypoxia-ischemia in mice. Stroke 35:2183-8
Marcus, A J; Broekman, M J; Drosopoulos, J H F et al. (2003) Heterologous cell-cell interactions: thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase-1). J Thromb Haemost 1:2497-509
Ten, Vadim S; Bradley-Moore, Maria; Gingrich, Jay A et al. (2003) Brain injury and neurofunctional deficit in neonatal mice with hypoxic-ischemic encephalopathy. Behav Brain Res 145:209-19

Showing the most recent 10 out of 39 publications